The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of EU Regulation 596/2014 (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018) ("UK MAR"). Upon the publication of this announcement via a Regulatory Information Service, this information is considered to be in the public domain.
For immediate release
2 December 2024
BOSTON INTERNATIONAL HOLDINGS PLC
("BIH" or the "Company")
Completion of Subscription by Zarara Energy Ltd for New Ordinary Shares in the Company and Total Voting Rights
The board of directors of BIH (the "Board") is pleased to announce that completion of the subscription by Zarara Energy Ltd ("ZEL") for 222,407,081 new ordinary shares of 0.1 pence each in the Company (the "Subscription Shares") for £306,000 in cash took place on 29 November 2024 ("Completion"). The Subscription Shares were allotted and issued by the Company to ZEL credited as fully paid up and ranking pari passu, and as one class with, the existing 148,219,943 ordinary shares in the Company. The Subscription Shares represent 60.00% of the enlarged issued share capital of the Company.
No application is being made for the present time for the Subscription Shares to be admitted to listing on the FCA's Official List or to trading on the London Stock Exchange's main market for listed securities. In any event, the listing and trading in the Company's existing issued ordinary shares is currently suspended.
Board changes
On Completion, Said Mbarak Salim Al Digeil and William ('Brock') Henry Tuppeny III (nominee Directors of ZEL) were appointed to the Board and Martin Lampshire and Richard Hartheimer resigned from the Board.
Conversion of Outstanding Directors' Fees and Expenses into New Convertible Loan Notes
As a result of Completion, the conversion of outstanding Directors' fees and expenses due from the Company to them and their consultancy companies into an aggregate principal amount of £246,982.20 New Convertible Loan Notes (as announced by the Company on 29 October 2024) has become effective.
Total voting rights
Following the allotment and issue of the 222,407,081 Subscription Shares, the Company's issued share capital consists of 370,627,024 ordinary shares of 0.1 pence, each with one voting right. The Company does not hold any ordinary shares in treasury. Therefore, the total number of voting rights in the Company is 370,627,024.
The above figure of 370,627,024 should be used by shareholders in the Company as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
For more information, please contact:-
Boston International Holdings Plc |
| |
Christopher Pitman, Chairman | +44 (0) 7768 104329 | |
Beaumont Cornish Limited (Rule 3/Financial adviser) | | |
Roland Cornish / Asia Szusciak | +44 (0) 20 7628 3396 | |
Important Notice:-
Beaumont Cornish Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is financial adviser to the Company in relation to the matters referred herein and the independent adviser to the Directors of the Company for the purposes of Rule 3 of the Takeover Code. Beaumont Cornish Limited is acting exclusively for the Company and for no one else in relation to the matters described in this announcement and is not advising any other person and accordingly will not be responsible to anyone other than the Company for providing the protections afforded to clients of Beaumont Cornish Limited, or for providing advice in relation to the contents of this announcement or any matter referred to in it.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.